Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

In its update, GSK reported a 17% rise in speciality medicines across its HIV, cancer and respiratory business to £2.93 ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

AZ has already thrown down a marker for its tougher stance on Europe with an earlier decision to abandon a $560 million vaccine manufacturing plant initially intended for the UK, sparking speculation ...

Grambley discusses how AI can be leveraged to create highly personalised patient engagement strategies, tailored to ...

For some patients, specialist pre-referral advice would let them start treatment in primary care quicker and in turn reduce the pressures on waiting lists. NHS Wales is using technology that allows ...